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ABSTRACT
The use of bacterial artificial chromosomes (BACs)
provides a consistent and high targeting efficiency
of homologous recombination in embryonic stem
(ES) cells, facilitated by long stretches of sequence
homology. Here, we introduce a BAC targeting
method which employs restriction fragment length
polymorphisms (RFLPs) in targeted polymorphic
C57BL/6/Cast/Ei F1 mouse ES cell lines to identify
properly targeted ES cell clones. We demonstrate
that knockout alleles can be generated either by tar-
geting of an RFLP located in the open reading frame
thereby disrupting the RFLP and ablating gene
function, or by introduction of a transcription stop
cassette that prematurely stops transcription of an
RFLP located downstream of the stop cassette.
With both methods we have generated Rnf12 het-
erozygous knockout ES cells, which were identified
by allele specific PCR using genomic DNA or cDNA
as a template. Our results indicate that this novel
strategy is efficient and precise, by combining a
high targeting efficiency with a convenient PCR
based readout and reliable detection of correct tar-
geting events.
INTRODUCTION
The discovery of mouse embryonic stem (ES) cells and the
possibility to manipulate the ES cell genome through
homologous recombination has provided a powerful meth-
odology to study gene function in vitro and in vivo (1–3).
Initial studies indicated that key factors important for ef-
ﬁcient gene targeting include the length of the targeting
arms, which positively correlates with the targeting efﬁ-
ciency (4,5), and the use of isogenic DNA for the gener-
ation of targeting constructs, as the presence of SNPs in a
targeting vector would reduce the targeting efﬁciency (4,6).
Increased targeting efﬁciency was obtained by targeting of
mouse ES cells with a bacterial artiﬁcial chromosomes
(BAC) strategy. Several annotated BAC libraries are
now available for different mouse laboratory strains, to
target a variety of different ES cell lines with isogenic tar-
geting vectors (http://www.ncbi.nlm.nih.gov/clone/).
Correct targeting with BAC targeting vectors is generally
veriﬁed by quantitative real-time PCR (Q-PCR) amplify-
ing a fragment spanning the projected deletion/insertion,
together with a Q-PCR amplifying a fragment located in
one of the arms (7). Also DNA–FISH has been applied to
determine a correct genetic modiﬁcation (8). However,
because conventional Southern blotting techniques cannot
be applied, these techniques are prone to detect false posi-
tive and negative clones. To avoid this problem, BAC tar-
geting vectors are used that have both short and long
targeting arms, allowing detection and/or conﬁrmation
of positive clones by Southern blotting using an external
probe (9). This requires a BAC that is properly positioned
around the insertion site, or is modiﬁed by trimming one
of the arms through homologous recombination in bac-
teria. Together, the current strategy still is associated with
several problems. In view of this, we have developed a new
BAC targeting strategy which makes use of RFLPs
present in genetically polymorphic ES hybrid cell lines,
generated by crossing C57BL/6 female mice with Cast/Ei
male mice, providing a convenient readout for proper gene
targeting. In the present study, the proof of principle target
gene was Rnf12, which encodes a nuclear factor involved
in X chromosome inactivation (XCI) (10). For this gene,
our results indicate that the new strategy can be used to
efﬁciently introduce genetic modiﬁcations in ES cells using
BAC targeting cassettes combined with a reliable readout
based on allele speciﬁc PCR.
MATERIALS AND METHODS
ES cell derivation and cell culture
Female C57BL/6 mice were crossed to male Cast/Ei mice,
and blastocysts were seeded onto irradiated mouse embry-
onic ﬁbroblasts (MEFs) in DMEM, 15% v/v knockout
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1 penicillin,
100mgml
1 streptomycin, non-essential amino acids,
0.1mM ß-mercaptoethanol, 5000Uml
1 leukemia inhibi-
tory factor (LIF) and 50mM MEK1 inhibitor (New
England Biolabs). The dissociated inner cell mass out-
growth was seeded on new feeders and after one passage
grown in standard ES medium containing DMEM, 15%
v/v fetal calf serum, 100Uml
1 penicillin, 100mgml
1
streptomycin, non-essential amino acids, 0.1mM
ß-mercaptoethanol and 1000Uml
1 LIF. To induce dif-
ferentiation, ES cells were split, and pre-plated on non-
gelatinized cell culture dishes for 60min. ES cells were
then seeded in non-gelatinized bacterial culture dishes
containing differentiation medium to induce embryoid
body (EB) formation. EB-medium consisted of IMDM-
glutamax, 15% v/v fetal calf serum, 100Uml
1 penicillin,
100mgml
1 streptomycin, non-essential amino acids,
37.8mll
1 monothioglycerol and 50mgml
1 ascorbic acid.
To generate chimeras, C57BL/6 mice where superovulated
and mated, and Day 3, 5 blastocysts were isolated. ES
cells were injected, and the embryos were transfered to
pseudopregnant foster mothers. Chimeras were crossed
to C57BL/6 mice, and germ line transmission was judged
by coat color. All animal experiments were in accordance
with the regulations of the Erasmus MC Animal
Experimental commission.
RFLP analysis and genotyping
To conﬁrm the parental origin of the derived C57BL/6/
Cast/Ei hybrid mouse ES cells, RFLP analysis on genomic
DNA was performed by PCR followed by restriction di-
gestion using the following primers and enzymes: Xist CA
GTGGTAGCTCGAGCCTTT and CCAGAAGAGGG
AGTCAGACG, BsrGI; Cdyl: ACAGGCAGAAGGAG
CTGTGT, and CCCAGCTGTAAAGGCTTCAG, ZraI.
Sry was ampliﬁed using ATTTATGGTGTGGTCCCG
TGGT and TATGTGATGGCATGTGGGTTCC.
Karyotyping, RNA–FISH and DNA–FISH
For karyotyping, cells were blocked in metaphase using
colcemid, and metaphase spreads were prepared by hypo-
tonic treatment, followed by ﬁxation in methanol acetic
acid (3:1 v/v), according to standard procedures. Xist
RNA–FISH and DNA–FISH were performed as described
(10). For DNA–FISH, a mouse BAC probe (RP24-240J16)
covering the Rnf12 gene was digoxigenin-labeled and used
to determine the number of integration sites of the Rnf12
targeting constructs. A cocktail containing biotin-labeled
BAC sequences covering Xist (CT7-474E4, CT7-45N16,
CT7-155J2 and CT7-211B4) was used as a probe to deter-
mine the number of X chromosomes.
RT–PCR
RNA was isolated from undifferentiated ES cells using
Trizol reagent (Invitrogen), according to manufacturers’
instruction, and cDNA was prepared using the SuperScript
TM III First-Strand Synthesis System (Invitrogen). RT–
PCR for pluripotency markers was performed using the
following gene speciﬁc primers: Oct4: CCCCAATGCCG
TGAAGTTG, TCAGCAGCTTGGCAAACTGTT;
Nanog: AGGATGAAGTGCAAGCGGTG, TGCTGAG
CCCTTCTGAATCAG; Sox2: CACAGATGCAACCGA
TGCA, GGTGCCCTGCTGCGAGTA; ß-Actin: CAAC
GAGCGGTTCCGATG, GCCACAGGATTCCATACC
CA.
Construction of targeting constructs
The Rnf12 targeting construct has been described (10). To
generate the SA-tpA stop constructs, a cassette containing
a ﬂoxed splice acceptor and polyadenylation sequence and
a Frt site ﬂanked neomycin/kanamycin fusion gene was
generated, starting with a pEGFP-NI vector (Clontech). A
linker containing a Lox66 and EcoRV, BglII and BamHI
sites together with a linker containing a Lox71 and Frt
sites ﬂanking a ScaI site were cloned BglII-NotI into
pEGFP-N1, releasing EGFP (complete sequence: GATC
TAATATAACTTCGTATAGCATACATTATACGAA
CGGTAGATATCAGATCTGGATCCTATTGAAGCA
TATTACATACGATATGCTTGCCATTTAATTCCGG
AGAATCCGGGAAGTTCCTATTCTCTAGAAAGTA
TAGGAACTTCAGTACTGAAGTTCCTATTCTCTA
GAAAGTATAGGAACTTCTAGG). The ScaI site was
used to insert a DraIII-AseI kanamycin/neomycin
fragment. The SA-tpA sequence was a BamHI fragment
from pSStpA (11), inserted in the BamHI site of the linker.
Three unique restriction sites in introns 2–4 of Rnf12 were
PCR ampliﬁed, with 500bp of ﬂanking region, and cloned
into pPCR-Topo-bluntII, using the following primers and
unique restriction sites: intron 2 BglII GGGCTACACAG
AGAAAGAAACC, AGCCATGCATGCTTGTGTTA;
intron 3 NheI GAAACAGCTTGTTTTATAATGTTTC
TT, TTGAACATGTGTTGCAAAATTAC; intron 4
AvrII ACATTTTGTTTGGGGAGGTG, GAATTGTG
CAACTCGGAACA. The SA-tpA kanamycin/neomycin
cassette was NheI-AﬂII released and inserted into the
unique restriction sites of the intronic targeting constructs.
The ﬁnal constructs were used for homologous recombin-
ation in bacteria of a C57BL/6 BAC RP24-240J16 (12).
Positive clones were screened by PCR for the correct re-
combination event using primers ﬂanking the homologous
recombination arms of the targeting constructs and insert
speciﬁc primers: Rnf12 intron 2 AAAGGTTTTGGCTGG
ATGGT, rev TGTGCCATAATGCTTGGCTA, Rnf12
intron 3 CCCAGGTAAGCTGCATGTAA, rev TGTA
GTCTTCTGAGCAACTCTTCC, Rnf12 intron 4 ACA
GAGCCCCGATGAAAAT, rev ACACGATTAGGAC
ACTCATGG.
Targeting of ES cells
Targeting constructs were linearized by PI-SceI digestion.
For each electroporation, 40mg of DNA and 1.010
6
ES cells were used. Cells were seeded on drug resistant
male MEFs, and selection with neomycin (270mgml
1,
active) was started 24h posttransfection and continued
for 7–12 days. Drug resistant clones were picked and
expanded.
RFLP analysis of targeted ES clones
Genomic DNA (gDNA) of ES clones was isolated, and
RFLP analysis was performed using the following primers
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AGCCGGACTAATCCAAACA, NheI; Xist CAGTGGT
AGCTCGAGCCTTT and CCAGAAGAGGGAGTCA
GACG, BsrGI. For analysis of cell lines targeted with
the stop constructs, RNA was isolated, cDNA prepared
and expression of Rnf12 was analyzed by RFLP analysis
using primers TAAAGAGGGTCCACCACCAC and GG
CAGAGAGCCACTTTCATC followed by NheI restric-
tion digestion.
Q-PCR copy number analysis
Copy number of genomic sequences was determined by
real time Q-PCR with genomic DNA using the following
primers: Rnf12 (NheI site): GTTCGTCCTGGAGAATA
CCG, GGAAAAGGTACGCCTAAAACC; Rnf12: AGC
CCCGATGAAAATAGAGG, GGCATTTCTGGATAA
TCTTTGG; Zfp42: GCACCCATATCCGCATCCAC, G
CATTTCTTCCCGGCCTTTG.
Southern blotting
An amount of 5–10mg of genomic DNA was digested over-
night with NheI, and separated on a 0.7% agarose gel.
DNA was blotted to Hybond membranes using standard
procedures, and the blot was hybridized with a PCR
ampliﬁed probe (primers: GGCAGAGAGCCACTTTC
ATC, GCCAAAGACCTCCAACCATA)
RESULTS
Existing methodology for screening positive clones after
homologous recombination with BAC targeting cassettes
involves Q-PCR or DNA–FISH. These methods are prone
to detect false positive and negative clones, and we there-
fore set out to develop a method to screen targeting events
by using RFLPs in F1 hybrid cell lines. In the ﬁrst ap-
proach the BAC targeting vector destroys the RFLP and
inserts a kanamycin/neomycin resistance cassette in the
open reading frame of the gene of interest, thereby
ablating gene function [Figure 1A(I)]. Removal of the
RFLP can be screened by PCR using genomic DNA as
a template and subsequent digestion of the PCR product
with the restriction enzyme recognizing the targeted RFLP.
In another approach, we introduce a splice acceptor
poly-adenylation transcription stop cassette (SA-tpA) in
an intron of the gene of interest, prematurely abrogating
gene transcription resulting in a non-functional protein.
For this second approach, positive clones are identiﬁed
by RT–PCR ampliﬁcation of a cDNA sequence, which
contains an RFLP that is located downstream of the tran-
scription stop cassette [Figure 1A(II)].
Generation of F1 ES hybrid cell lines
To obtain genetically polymorphic ES cell lines with a
high number of RFLPs that could be used for gene tar-
geting, we generated F1 hybrid ES cell lines by crossing
C57BL/6 female mice with Cast/Ei male mice. The
C57BL/6 classical inbred Mus musculus mouse strain is
among the most widely used and best characterized
mouse strains. The C57BL/6 mouse genome has been
sequenced, and several well-annotated BAC libraries
have been generated (13). The Cast/Ei inbred strain has
been derived from a wild population of the subspecies Mus
musculus castaneus, is more difﬁcult to breed, but offers
advantages related to its variant genetic background (14).
Intercrosses between Cast/Ei and other strains have been
extensively used for SNP based distinction of the maternal
and paternal genome, for instance to study genomic im-
printing and XCI. The C57BL/6 and Cast/Ei mouse
strains are highly polymorphic, with an estimate of one
SNP per 311bp, providing a sufﬁcient number of RFLPs
to allow targeting of almost every gene (14). The Cast/Ei
Mus m. subspecies is currently being sequenced, a BAC
library is available, and a SNP database is publically
accessible (www.perlegen.com).
We generated ﬁve different F1 ES cell lines, with the pro-
per karyotype and ES cell morphology, which were suc-
cessfully differentiated into EBs (Figure 1B). RT–PCR
expression analysis conﬁrmed expression of the pluripo-
tency markers Oct4, Sox2 and Nanog (Figure 1C).
Karyotyping and PCR analysis of genomic DNA with a
primer set speciﬁc for Sry showed that three ES cell lines
were male and two female (Figure 1D). We conﬁrmed the
C57BL/6/Cast/Ei F1 genotype by PCR ampliﬁcation of
the autosomal gene Cdyl and the X-linked gene Xist,
and digestion with restriction enzymes speciﬁc for
RFLPs that discriminate between a C57BL/6 or Cast/Ei
PCR product (ZraI for Cdyl, and BsrGI for Xist).
Digestion of the Xist PCR products from genomic DNA
(gDNA) of the male ES cell lines revealed only a C57BL/6
product, as expected, because the single X chromosome in
male cells is inherited from the C57BL/6 mother. Two
male ES cell lines, E3 and E14, were injected in C57BL/
6 blastocysts and several founders (ﬁve for E3, two for
E14) were retrieved, all showing high coat color contribu-
tion (representative animals are shown in Supplementary
Figure S1). Different founders were crossed with C57BL/6
females and all tested animals showed germline transmis-
sion (Figure 1E). Taken together, we generated three male
and two female C57BL/6/Cast/Ei F1 ES cell lines. Because
of our interest in the female speciﬁc XCI process female
ES line E15 was used for further targeting studies.
Targeted disruption of the Rnf12 open reading frame
For BAC mediated targeting of an RFLP we selected the
X-chromosomal Rnf12 gene as a target (Figure 2A). We
have recently shown that the encoded RNF12 acts as a
dose-dependent activator of XCI in female ES cells
(10,15,16). RNF12 is an E3 ubiquitin ligase that regulates
XCI through activation of the X-linked gene Xist (16).
The transcribed Xist RNA coats the inactive X chromo-
some in cis (Figure 1B), thereby attracting chromatin
modifying enzymes involved in establishing inactive chro-
matin (17).
Rnf12 consists of ﬁve exons, spanning 24kb. In the SNP
database we identiﬁed NheI as an RFLP located in exon 5
of the C57BL/6 Rnf12 allele, and conﬁrmed the RFLP by
sequencing analysis of gDNA isolated from C57BL/6 and
Cast/Ei mice. Disruption of RNF12 activity by insertion
of a neomycin/kanamycin resistance cassette in this NheI
RFLP would lead to a premature translation stop of
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RING ﬁnger that is crucial for RNF12 activity. Based on
this, we generated a targeting construct to disrupt Rnf12,
by PCR ampliﬁcation of the NheI RFLP and 500bp of
ﬂanking sequence, and subsequent insertion of a kanamy-
cin/neomycin resistance cassette in the NheI site. The
C57BL/6 BAC RP24-240J16, covering the Rnf12 gene,
was targeted through homologous recombination in
bacteria (12), and correct targeting was conﬁrmed by
PCR ampliﬁcation using primers inside the resistance cas-
sette and outside the targeting arms (data not shown). The
targeting efﬁciency in bacteria was >80%. The modiﬁed
BAC sequence was linearized with SceI and targeted to
female ES cell line E15, and subsequent to neomycin se-
lection clones were picked and expanded for further ana-
lysis. Genomic DNA of these clones was subjected to PCR
using primers spanning the targeted NheI site, and the
PCR product was digested with NheI. Correctly targeted
Figure 1. Two approaches of a new strategy for manipulation of hybrid mouse ES cell lines. (A) Schematic overview of RFLP mediated BAC
targeting of hybrid C57BL/6/Cast/Ei ES cells. Chromosomes from C57BL/6 are indicated with B6 and from Cast/Ei with Cast. Exons of the gene of
interest are indicated in green, the kanamycin/neomycin resistance cassette in white, and the transcription stop cassette in black. (B) C57BL/6/Cast/Ei
hybrid ES cells show proper ES cell morphology (left panel), are able to differentiate in vitro in EBs (middle panel), and female lines can initiate XCI
upon differentiation (right panel, showing Xist RNA labeled in FITC, and DNA stained with DAPI). (C) RT–PCR of pluripotency genes. The
generated C57BL/6/Cast/Ei ES cells (E3–E15) express the pluripotency factors Oct4, Sox2 and Nanog. J1 is a male control ES cell line, MEFs were
used as negative control, and Actin is a control mRNA. (D) PCR ampliﬁcation of gDNA of different C57BL/6/Cast/Ei ES cell lines (E3–E15) and
control gDNA (Cas and B6), and digestion with restriction enzymes identifying allele speciﬁc products for Xist (X-encoded, BsrGI, top panel), Cdyl
(autosomal, ZraI, middle panel) and PCR ampliﬁcation of Sry (Y-encoded, bottom panel). (E) Table summarizing the characteristics of the C57BL/
6/Cast/Ei ES cell lines analyzed in this study, and two other polymorphic 129/Sv/Cast/Ei cell lines (Asterisk) that have been used in other gene
targeting studies (10).
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only, although contamination by feeder cells (C57BL/6)
might result in the presence of some digested material
(Figure 2B). We therefore also grew the targeted clones
without feeders, which indicated that 12% of the picked
clones showed a loss of the C57BL/6 speciﬁc PCR product
(Figures 2C and 3C).
Our results were conﬁrmed by Q-PCR analysis with
primers spanning the NheI site, which indicated a reduc-
tion in copy number from two to one, and primers amp-
lifying a region proximal to the NheI site, indicating no
change in the copy number (Figure 2E). The loss of one
NheI site could be attributed to a correct targeting event,
or loss of an X chromosome. Although the Q-PCR results
indicated that both X chromosomes were present, we also
performed a PCR ampliﬁcation of a BsrGI polymorphism
in the Xist gene. Digestion of the PCR products with
BsrGI, which only digests the C57BL/6 PCR product,
indicated that both X chromosomes were present in all
clones that showed a loss of the C57BL/6 Rnf12 PCR
product (Figure 2D). We conﬁrmed this ﬁnding by
DNA–FISH with two different probes, one covering the
BAC used for targeting the ES cells, and the other covering
Xist and ﬂanking sequences. We found that clones that
lost the RFLP had retained the expected 40, XX karyo-
type, providing evidence for a correct targeting event, and
precluding the presence of randomly integrated BACs
(Figure 2F). Finally, genomic DNA of targeted clones was
subjected to Southern blotting analysis, which indicated
the correct targeting event; loss of the C57BL/6 speciﬁc
5.4-kb band in knockout clones that were selected based
on the RFLP PCR assay and no loss in control clones
(Figure 2G).
Analysis of all our targeted clones indicated that target-
ing with a C57BL/6 construct, was speciﬁc for the C57BL/
6 allele. However, our previous studies also indicated
that the same construct can be used to target the 129/Sv
allele in F1 2-1 129/Sv/Cast/Ei female ES cells (10).
Figure 2. Generation of Rnf12 knockout ES cell lines by disruption of the Rnf12 open reading frame. (A) Targeting of Rnf12 by insertion of a
kanamycin/neomycin resistance cassette into the exon containing a NheI RFLP destroys the RFLP (present in the C57BL/6 allele). (B) PCR analysis
with primers indicated in Figure 2A amplifying the NheI RFLP located in Rnf12 using genomic DNA of targeted clones 1–7. PCR fragments were
digested with NheI. (C) Same as in Figure 2B, but with gDNA isolated from clones 2, 6 and 10, grown without feeder cells. Cast/Ei (Cas), C57BL/6
(B6) and Cast/Ei / C57BL/6 (F1) DNA was used as a control (m=marker). (D) Same as in Figure 2C, but PCR analysis amplifying the BsrGI
RFLP located in Xist using gDNA of the targeted clones. PCR fragments were digested with BsrGI. (E) Q-PCR analysis with primers indicated using
gDNA of different targeted clones. Values were normalized to values obtained with a primer set amplifying the autosomal Zfp42 gene. (F) DNA–
FISH analysis with a BAC probe covering the targeting cassette (FITC), and a mix of BAC probes detecting Xist and ﬂanking regions (Rhodamine
red) (DNA stained with DAPI). (G) Southern blotting analysis, using a probe that distinguishes between the Cast/Ei (8.1kb) and C57BL/6 (5.4kb)
alleles. A neo insertion event destroying the NheI RFLP present on the C57BL/6 allele results in a 10.3-kb fragment (clones 2, 6 and 10). (H) Three
different Rnf12
+/ ES cell lines and a wild-type female ES cell line were differentiated, and subjected to Xist RNA FISH. The relative number of cells
showing an Xist cloud, indicative for initiation of XCI, is shown at different time points of differentiation (N>100 per time point, error bars
represent 95% conﬁdence intervals).
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probably due to the presence of SNPs in the targeting
construct (Figure 3C). Using a Cast/Ei targeting construct
in which kanamycin/neomycin was replaced by a
ampicilin/puromycin resistance cassette, we were also
able to target the Cast/Ei allele, resulting in a homozygous
Rnf12
/– ES cell line (16). In this experiment the efﬁciency
was lower (3%) than found for the C57BL/6 construct
targeting the C57BL/6 allele, possibly due to selection
against cells deﬁcient for Rnf12 (Figure 3C).
To demonstrate the value of the strategy described
herein for studying a speciﬁc cellular process, we tested
the effect of the heterozygous Rnf12 deletion on XCI.
We analyzed the percentage of cells that initiated XCI,
by Xist RNA FISH at different time points of EB differ-
entiation, for three Rnf12
+/– clones. Previously, we found
that a heterozygous deletion of Rnf12 in female cells
results in a signiﬁcant reduction of XCI, as part of the
evidence that RNF12 is an important activator of XCI
(10). In agreement with this, analysis of the present
C57BL/6/Cast/Ei Rnf12
+/ female ES lines also showed
a reduction in the number of cells that initiated XCI
(Figure 2H). These results indicate that homologous re-
combination of RFLPs with BAC targeting constructs
provides an efﬁcient and precise method to generate
knockout ES cell lines.
Premature abrogation of Rnf12 transcription
Even in the highly polymorphic ES cells used for the pre-
sent study, a relatively small percentage of all genes will
not contain suitable RFLPs to allow targeting of a resist-
ance cassette abolishing expression of a functional tran-
script. For such genes, a splice acceptor triple poly-
adenylation (SA-tpA) cassette could be used to insert into
an intronic RFLP, thereby leading to a premature stop of
transcription. Alternatively, a SA-tpA cassette could be
inserted into an intron of the gene of interest, using a
transcribed RFLP located downstream of the insertion
site to screen for proper integration. Both modiﬁcations
of the present method provide many more possible target-
ing sequences. As proof of principle, we generated target-
ing vectors aimed to prematurely stop transcription in one
of the introns 2, 3 or 4 of Rnf12 (Figure 3A). BAC target-
ing cassettes were generated through homologous recom-
bination of a SA-tpA cassette ﬂanked by a kanamycin/
neomycin resistance cassette in different introns of Rnf12
in C57BL/6 BAC RP24-240J16. Proper integration of the
SA-tpA cassette was veriﬁed by PCR (data not shown),
and the targeting vectors were electroporated into female
E15 C57BL/6/Cast/Ei ES cells. Neomycin resistant clones
were expanded without feeder cells for RNA isolation. To
determine the clones with a proper integration of the
SA-tpA cassette abolishing Rnf12 expression from the tar-
geted C57BL/6 allele, we generated cDNA and performed
RT–PCR amplifying the exons 4 and 5 junction of Rnf12
including the previously described NheI RFLP. Allele
speciﬁc expression was determined by digestion of the
RT–PCR product with NheI, which only digests the
C57BL/6 PCR product. For each targeting vector we ob-
tained positive clones which showed expression of the
Cast/Ei allele only, indicating proper integration of the
transcription stop cassette (Figure 3B). Loss of an X
chromosome was ruled out by PCR ampliﬁcation of a
BsrGI RFLP located in the Xist gene, using gDNA and
subsequent digestion with BsrGI (data not shown). The
targeting efﬁciencies were 4, 8 and 12%, for targeting of
introns 2–4, respectively, which is in the range of
Figure 3. Generation of Rnf12 knockout ES cell lines by insertion of a
transcription stop cassette. (A) Generation of Rnf12 knockout ES cell
lines by integration of a splice acceptor triple poly-adenylation
sequence (SA-tpA) together with a kanamycin/neomycin resistance
cassette. Different targeting constructs were generated to target the
stop cassette to one of the introns 2, 3 or 4. (B) RT–PCR analysis
with cDNA form clones targeted with cassettes targeting different
introns, using primers amplifying the NheI RFLP located in exon 5.
RT–PCR products were digested with NheI to reveal allele speciﬁc
PCR products. Correctly targeted clones are indicated (ko). (C) Table
summarizing the targeting efﬁciency of the constructs described for
targeting the C57BL/6 allele (n=number of clones picked). (Asterisk)
Targeting efﬁciencies of previously described experiments involving
C57BL/6, and Cast/Ei exon 5 targeting constructs used to target the
129/Sv and Cast/Ei alleles in F1 2-1 129/Sv/Cast/Ei female ES cells
(10,16). (Double asterisk) The Cast/Ei allele was targeted in Rnf12
+/
(129/Sv/Cast/Ei) ES cells creating a Rnf12 null ES cell, which may
affect the targeting efﬁciency.
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constructs (8). These results indicate that different target-
ing methods, either removing an RFLP or ablating expres-
sion of an RFLP combined with an allele speciﬁc PCR to
detect a correct targeting event, can be applied to intro-
duce genetic modiﬁcations in ES cells.
DISCUSSION
Previous attempts to generate genetically modiﬁed ES cell
lines by homologous recombination of BAC targeting
vectors have been challenging, mainly because a clear
readout for proper integration of the targeting cassette
was missing. Here, we have generated and targeted F1
C57BL/6/Cast/Ei hybrid ES cell lines, which are genetic-
ally polymorphic, carrying a high density of RFLPs.
We have opted for two different approaches for BAC
mediated gene targeting, both using RFLPs as a readout
for properly targeted clones. In one strategy a resistance
cassette is integrated into the open reading frame of a
gene, ablating gene function and disrupting the RFLP.
In another approach, a splice acceptor transcription stop
cassette is inserted in a transcribed RFLP, or in a genomic
location upstream of an RFLP, and subsequently the
RFLP is used to detect loss of expression of the targeted
allele. The last strategy can even be used to generate con-
ditional knockout or rescue alleles, by using inverted asym-
metric lox sites. The combination of these approaches
provides an opportunity to disrupt a wide selection of can-
didate target genes. Nonetheless, even in the F1 C57BL/6/
Cast/Ei ES cell lines for some genes no RFLPs will be
available. Especially, single exon genes or genes covering
a relative small genomic region may not entail enough
SNPs for the design of a proper targeting approach.
Also, the targeting strategy based on screening of ex-
pressed RFLPs requires the targeted gene to be expressed
in ES cells. Fortunately, this is true for many genes and
even genes which only play a role in embryonic develop-
ment and differentiation processes appear to be expressed
at a base level in ES cells, sufﬁcient to allow application of
the second approach.
The targeted F1 C57BL/6/Cast/Ei ES cell lines can
directly be used to study the effect of the mutation
introduced in vitro, or can be used for the generation of
mice, either through the generation of chimeric mice by
injection of ES cells in a diploid blastocyst or by the tetra-
ploid complementation technology (18). For several
studies, the analysis of mutant mice generated with these
hybrid ES cell lines requires extensive back crossing.
However, mice generated by tetraploid complementation
could avoid this problem. Also, the effect of many muta-
tions can be studied in hybrid mice, and for studies
involving genomic imprinting and X inactivation a
hybrid back ground is even the preferred back ground
for studying the consequence of an introduced mutation.
Regarding efﬁciency of the new strategy, for targeting
of the Rnf12 locus, we ﬁnd that analysis of less than a
hundred clones results in a sufﬁcient number of properly
targeted cell lines (Figure 3C), in agreement with previous
ﬁndings using homologous recombination with BAC
targeting vectors (8). Although there is neither a gain or
loss in efﬁciency, the use of RFLPs to perform an allele
speciﬁc PCR profoundly facilitates the detection of posi-
tive clones, and omits less reliable and more laborious
techniques such as DNA–FISH and Q–PCR. Therefore,
our new strategy for gene targeting combines the high ef-
ﬁciency of BAC targeting technology with a convenient
readout to screen for positive targeting events. The
highly polymorphic C57BL/6/Cast/Ei ES cell lines we
generated, in combination with the different approaches
described here, for targeting a gene of interest, provides
many options for efﬁcient and precise BAC targeting of
almost every gene in the mouse genome.
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Supplementary Data are available at NAR Online.
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